# The Purpose of This Study is to Investigate the Safety, Tolerability and Pharmacokinetics of MT-7117 in Healthy Subjects.

> **NCT06994286** · PHASE1 · COMPLETED · sponsor: **Tanabe Pharma Corporation** · enrollment: 40 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** MT-7117
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06994286
- **Lead sponsor:** Tanabe Pharma Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-06-24
- **Primary completion:** 2025-07-21
- **Final completion:** 2025-08-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06994286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06994286, "The Purpose of This Study is to Investigate the Safety, Tolerability and Pharmacokinetics of MT-7117 in Healthy Subjects.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06994286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*